Feasibility Analysis
Executive Finding
The Rev 1 instrument is feasible as a research-use-only heater and colorimetric measurement platform. It is not sufficient by itself to detect or distinguish COVID-19, influenza, or other viruses. Analytical performance is governed primarily by the validated assay, primers, sample preparation, controls, and interpretation protocol.
What Rev 1 Can Prove
- Controlled heating of one sealed 0.2 mL PCR tube.
- Repeatable illumination and RGB/clear optical measurement.
- Real-time tracking of a colorimetric reaction.
- Standalone user interface and safety/fault behavior.
- Exportable engineering measurements for assay-development research.
What Rev 1 Cannot Establish
- Clinical sensitivity, specificity, limit of detection, or cross-reactivity.
- Reliable direct-from-saliva testing without a validated pretreatment workflow.
- Identification of several viruses from one generic reaction.
- A medically actionable result.
Assay Boundary
The target is selected by the LAMP primer set and reagent formulation, not by the reader. COVID-19, influenza A, influenza B, and other targets require separately validated primer sets and normally separate reactions unless a specific multiplex assay has been developed and validated.
A single-tube reader can measure one reaction at a time. A credible assay workflow also requires controls, commonly including a no-template control, positive control, and/or internal human-sample control. These must be run sequentially on Rev 1, so the platform is primarily an instrumentation prototype rather than a complete diagnostic workflow.
For Rev 1, each tube is assigned a target/assay identifier, a role (sample, no-template control, positive control, or sample/process control), and a run-set identifier. The device can record those labels but cannot infer whether the assay design itself is valid.
Colorimetric Chemistry Feasibility
Commercial pH-based colorimetric RT-LAMP workflows commonly use a pink-to-yellow response and approximately 65 °C incubation. A representative NEB protocol specifies 65 °C for 30 minutes, with some reactions requiring an additional 10 minutes. The optical system should therefore support configurable 60–70 °C setpoints and 10–60 minute runs rather than hard-coding one assay.
The sensor should collect both baseline and time-series data. Dynamic color measurement is preferable to a single endpoint because intermediate orange states and sample-dependent baseline colors can be ambiguous.
Saliva-Specific Risk
Direct saliva is a difficult input for pH-based colorimetry:
- Saliva varies in pH, color, viscosity, inhibitors, and RNase activity.
- Acidic saliva can shift phenol-red chemistry before amplification and create a false-positive-looking color.
- Strongly buffered sample media can suppress the intended color transition.
- Longer incubation can increase nonspecific amplification and false-positive risk.
Therefore Rev 1 shall not include raw-saliva loading or an automated clinical call. Initial testing should use optical reference solutions, thermal dummy tubes, and non-biological or synthetic control materials under an established laboratory protocol.
Before any saliva experiment, an assay protocol must define: collection method, time from collection to processing, pretreatment or extraction, inactivation method, saliva and reaction input volumes, acceptable starting pH/color range, incompatible buffers or contaminants, required controls, invalid-sample rules, and disposal. The reader must treat a pre-incubation optical baseline outside the validated range as invalid rather than as amplification.
Contamination Control
LAMP produces large quantities of amplicon, creating serious carryover-contamination risk. The instrument should:
- Keep reaction tubes sealed throughout and after the run.
- Avoid any post-amplification tube-opening step near reaction preparation.
- Use a removable, cleanable tube-well insert.
- Keep preparation and post-run areas physically separated.
- Prefer a validated dUTP/thermolabile-UDG workflow where compatible with the assay.
Thermal Feasibility
A compact aluminum block around one PCR tube can be heated with an approximately 15–20 W resistive heater. A 30 g aluminum block raised 40 °C stores roughly 1.1 kJ; including the tube, hardware, and heat loss, a practical 18 W system should be capable of reaching the setpoint within the 10-minute target when appropriately insulated. This must be verified experimentally because contact geometry and convection dominate actual performance.
Key thermal risks:
- Temperature sensor measures the block rather than the liquid; an offset must be characterized.
- Condensation at the tube cap may change concentration and obscure optical readings.
- A heated lid may eventually be required, but it is deliberately excluded from the simplest Rev 1 architecture unless testing demonstrates a need.
- Transparent printed materials must be isolated from the heater and selected for adequate temperature resistance.
The selected operating sequence is preheat first, then insert the sealed room-temperature tube into the guarded 65 °C block. This follows representative assay guidance that reactions should go directly onto a preheated block rather than warming with it. The instrument pauses heater drive during lid-open insertion and starts the assay timer only after a validated liquid-equilibration interval or model indicates the liquid is in band.
Thermal validation must use an instrumented liquid dummy, not only the block sensor. It must establish block-to-liquid offset, time to liquid setpoint, steady-state liquid tolerance, tube-to-tube variation, and whether condensation changes the reaction-zone volume or optical path.
Optical Feasibility
A controlled white or multi-channel LED on one side of the tube and an RGB/clear sensor on the opposite side is feasible. Rev 1 should measure transmitted light, take LED-off dark samples, and normalize channels to compensate for source intensity and tube variation.
Initial analysis candidates include ratios such as red/green, red/blue, hue, or CIE-derived values. The production metric cannot be selected until representative positive, negative, and invalid samples are measured.
Recommended Development Sequence
- Characterize heater block, sensor offset, warm-up time, stability, and overtemperature cutoff using a thermal dummy.
- Characterize optics with stable colored reference liquids across temperature.
- Measure known research controls in sealed tubes under an established protocol.
- Develop thresholds only after collecting repeated time-series datasets.
- Treat saliva workflows and pathogen assays as a separate bioscience validation program.
Staged Biological and Assay Plan
Stage A - Instrument Characterization
- Thermal dummy and stable colored standards only.
- Pass criteria: block and liquid temperature performance, optical repeatability, lid/dark checks, fault handling, and data export.
Stage B - Non-Infectious Amplification Controls
- Synthetic target material or other non-infectious research controls under a qualified laboratory protocol.
- Run target-specific positive, no-template, and process/internal controls sequentially.
- Pass criteria: predefined time-series separation, no control failures, and repeatability across days and reagent lots.
Stage C - Defined Prepared Sample Matrix
- Use a documented purified or prepared matrix with known pH, buffer, volume, and target concentration.
- Establish invalid-baseline rules, inhibition detection, working range, and preliminary limit of detection.
Stage D - Saliva Workflow Research
- Conduct only with appropriate biosafety, ethics, and laboratory oversight.
- Freeze the collection and preparation protocol before threshold evaluation.
- Evaluate interference, inclusivity, cross-reactivity, invalid rate, sensitivity, specificity, and controls independently of instrument verification.
Stage E - Multi-Target Platform Expansion
- Retain one target-specific reaction per run or redesign for several wells.
- A one-color tube cannot distinguish COVID-19, influenza A, and influenza B in one reaction. True multiplexing requires validated distinguishable signals, likely a different optical architecture.
Evidence
Go/No-Go Criteria
Proceed to an integrated PCB after the architecture review if:
- An 18–20 W heater is acceptable with the selected 12 V adapter.
- The block can be safely isolated from the transparent enclosure.
- The optical chamber can mechanically provide repeatable tube placement and darkness.
- The user accepts that assays, controls, and saliva preparation remain outside Rev 1 scope.